TURNER DANIEL K III 4
4 · Orexigen Therapeutics, Inc. · Filed May 28, 2010
Insider Transaction Report
Form 4
TURNER DANIEL K III
Director
Transactions
- Award
Stock Option (right to buy)
2010-05-27+20,000→ 20,000 totalExercise: $5.52Exp: 2020-05-26→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]1/12th of the original number of shares subject to the option vest on the first day of each calendar month following 5/27/2010. The shares shall become fully vested upon a change of control. These options have a post-termination exercise period of one year.
- [F2]Not applicable.